NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.
| Revenue (Most Recent Fiscal Year) | $2.28M |
| Net Income (Most Recent Fiscal Year) | $-3.71M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.71 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.58 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -111.16% |
| Net Margin (Trailing 12 Months) | -112.35% |
| Return on Equity (Trailing 12 Months) | -95.96% |
| Return on Assets (Trailing 12 Months) | -53.14% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.45 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.38 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.30 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.95 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.69 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 2.78M |
| Free Float | 2.68M |
| Market Capitalization | $2.03M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 1.54 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 16.39% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |